Genus Lifesciences
FDA Approved Drugs

Genus Lifesciences

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

RX Discontinued
  • Total Records 23
  • Latest Approval Date Nov 25, 2025
  • Data Source FDA
  • First Approval Date Jan 01, 1982
All
23
View
Discontinued
4
View
RX
19
View
Company Overview

Company

Genus Lifesciences

Country

U.S.A

Website

Visit Website

Email

iInfo@GenusLifesciences.com

Social Profiles

Company Snapshot

Genus Lifesciences

514 North 12th Street, Allentown, PA 18102

U.S.A

genuslifesciences.com/ iInfo@GenusLifesciences.com View on Map
FDA Approved Drug Records ( 23 records )
1982
01 Jan
RX Application: 87508

Drug Name

ACETAMINOPHEN AND CODEINE PHOSPHATE

Product Number

1

Dosage Form

-

Strength

120MG/5ML;12MG/5ML

Approval Date

1982-01-01

87508 / 1

Active Ingredient

ACETAMINOPHEN; CODEINE PHOSPHATE

Application Number

87508

Product Number

1

Dosage Form

-

Strength

120MG/5ML;12MG/5ML

Approval Date

1982-01-01

Regulatory Status

RX

2003
15 May
Discontinued Application: 76065

Drug Name

AMCINONIDE

Product Number

1

Dosage Form

-

Strength

0.1%

Approval Date

2003-05-15

76065 / 1

Active Ingredient

AMCINONIDE

Application Number

76065

Product Number

1

Dosage Form

-

Strength

0.1%

Approval Date

2003-05-15

Regulatory Status

Discontinued

2008
08 Feb
Discontinued Application: 40613

Drug Name

HYDROCODONE BITARTRATE AND HOMATROPINE METHYLBROMIDE

Product Number

1

Dosage Form

-

Strength

1.5MG/5ML;5MG/5ML

Approval Date

2008-02-08

40613 / 1

Active Ingredient

HOMATROPINE METHYLBROMIDE; HYDROCODONE BITARTRATE

Application Number

40613

Product Number

1

Dosage Form

-

Strength

1.5MG/5ML;5MG/5ML

Approval Date

2008-02-08

Regulatory Status

Discontinued

2003
06 Jun
RX Application: 21137

Drug Name

LEVOLET

Product Number

1

Dosage Form

-

Strength

0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2003-06-06

21137 / 1

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

21137

Product Number

1

Dosage Form

-

Strength

0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2003-06-06

Regulatory Status

RX

2003
06 Jun
RX Application: 21137

Drug Name

LEVOLET

Product Number

2

Dosage Form

-

Strength

0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2003-06-06

21137 / 2

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

21137

Product Number

2

Dosage Form

-

Strength

0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2003-06-06

Regulatory Status

RX

2003
06 Jun
RX Application: 21137

Drug Name

LEVOLET

Product Number

3

Dosage Form

-

Strength

0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2003-06-06

21137 / 3

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

21137

Product Number

3

Dosage Form

-

Strength

0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2003-06-06

Regulatory Status

RX

2003
06 Jun
RX Application: 21137

Drug Name

LEVOLET

Product Number

4

Dosage Form

-

Strength

0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2003-06-06

21137 / 4

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

21137

Product Number

4

Dosage Form

-

Strength

0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2003-06-06

Regulatory Status

RX

2003
06 Jun
RX Application: 21137

Drug Name

LEVOLET

Product Number

5

Dosage Form

-

Strength

0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2003-06-06

21137 / 5

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

21137

Product Number

5

Dosage Form

-

Strength

0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2003-06-06

Regulatory Status

RX

2003
06 Jun
RX Application: 21137

Drug Name

LEVOLET

Product Number

6

Dosage Form

-

Strength

0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2003-06-06

21137 / 6

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

21137

Product Number

6

Dosage Form

-

Strength

0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2003-06-06

Regulatory Status

RX

2003
06 Jun
RX Application: 21137

Drug Name

LEVOLET

Product Number

7

Dosage Form

-

Strength

0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2003-06-06

21137 / 7

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

21137

Product Number

7

Dosage Form

-

Strength

0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2003-06-06

Regulatory Status

RX

2003
06 Jun
RX Application: 21137

Drug Name

LEVOLET

Product Number

8

Dosage Form

-

Strength

0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2003-06-06

21137 / 8

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

21137

Product Number

8

Dosage Form

-

Strength

0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2003-06-06

Regulatory Status

RX

2003
06 Jun
RX Application: 21137

Drug Name

LEVOLET

Product Number

9

Dosage Form

-

Strength

0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2003-06-06

21137 / 9

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

21137

Product Number

9

Dosage Form

-

Strength

0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2003-06-06

Regulatory Status

RX

2003
06 Jun
RX Application: 21137

Drug Name

LEVOLET

Product Number

10

Dosage Form

-

Strength

0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2003-06-06

21137 / 10

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

21137

Product Number

10

Dosage Form

-

Strength

0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2003-06-06

Regulatory Status

RX

2003
06 Jun
RX Application: 21137

Drug Name

LEVOLET

Product Number

11

Dosage Form

-

Strength

0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2003-06-06

21137 / 11

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

21137

Product Number

11

Dosage Form

-

Strength

0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2003-06-06

Regulatory Status

RX

2003
06 Jun
RX Application: 21137

Drug Name

LEVOLET

Product Number

12

Dosage Form

-

Strength

0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2003-06-06

21137 / 12

Active Ingredient

LEVOTHYROXINE SODIUM

Application Number

21137

Product Number

12

Dosage Form

-

Strength

0.3MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium

Approval Date

2003-06-06

Regulatory Status

RX

2010
20 Oct
RX Application: 200534

Drug Name

OXYCODONE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2010-10-20

200534 / 1

Active Ingredient

OXYCODONE HYDROCHLORIDE

Application Number

200534

Product Number

1

Dosage Form

-

Strength

5MG

Approval Date

2010-10-20

Regulatory Status

RX

2010
20 Oct
RX Application: 200535

Drug Name

OXYCODONE HYDROCHLORIDE

Product Number

1

Dosage Form

-

Strength

100MG/5ML

Approval Date

2010-10-20

200535 / 1

Active Ingredient

OXYCODONE HYDROCHLORIDE

Application Number

200535

Product Number

1

Dosage Form

-

Strength

100MG/5ML

Approval Date

2010-10-20

Regulatory Status

RX

2013
22 Aug
RX Application: 200535

Drug Name

OXYCODONE HYDROCHLORIDE

Product Number

2

Dosage Form

-

Strength

5MG/5ML

Approval Date

2013-08-22

200535 / 2

Active Ingredient

OXYCODONE HYDROCHLORIDE

Application Number

200535

Product Number

2

Dosage Form

-

Strength

5MG/5ML

Approval Date

2013-08-22

Regulatory Status

RX

2025
25 Nov
RX Application: 206814

Drug Name

POKONZA

Product Number

3

Dosage Form

-

Strength

10MEQ/15ML

Approval Date

2025-11-25

206814 / 3

Active Ingredient

POTASSIUM CHLORIDE

Application Number

206814

Product Number

3

Dosage Form

-

Strength

10MEQ/15ML

Approval Date

2025-11-25

Regulatory Status

RX

2014
22 Dec
RX Application: 206814

Drug Name

POTASSIUM CHLORIDE

Product Number

1

Dosage Form

-

Strength

20MEQ/15ML

Approval Date

2014-12-22

206814 / 1

Active Ingredient

POTASSIUM CHLORIDE

Application Number

206814

Product Number

1

Dosage Form

-

Strength

20MEQ/15ML

Approval Date

2014-12-22

Regulatory Status

RX

2014
22 Dec
RX Application: 206814

Drug Name

POTASSIUM CHLORIDE

Product Number

2

Dosage Form

-

Strength

40MEQ/15ML

Approval Date

2014-12-22

206814 / 2

Active Ingredient

POTASSIUM CHLORIDE

Application Number

206814

Product Number

2

Dosage Form

-

Strength

40MEQ/15ML

Approval Date

2014-12-22

Regulatory Status

RX

2016
14 Sep
Discontinued Application: 205103

Drug Name

YOSPRALA

Product Number

1

Dosage Form

-

Strength

81MG;40MG

Approval Date

2016-09-14

205103 / 1

Active Ingredient

ASPIRIN; OMEPRAZOLE

Application Number

205103

Product Number

1

Dosage Form

-

Strength

81MG;40MG

Approval Date

2016-09-14

Regulatory Status

Discontinued

2016
14 Sep
Discontinued Application: 205103

Drug Name

YOSPRALA

Product Number

2

Dosage Form

-

Strength

325MG;40MG

Approval Date

2016-09-14

205103 / 2

Active Ingredient

ASPIRIN; OMEPRAZOLE

Application Number

205103

Product Number

2

Dosage Form

-

Strength

325MG;40MG

Approval Date

2016-09-14

Regulatory Status

Discontinued

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    0 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    23 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
23 total
  • RX
  • Discontinued
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ACETAMINOPHEN AND CODEINE PHOSPHATE

Application Number

87508

Product Number

1

Active Ingredient

ACETAMINOPHEN; CODEINE PHOSPHATE

Dosage Form

-

Strength

120MG/5ML;12MG/5ML

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit